Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 4/20 | 0.36 |
| ▸ | TERT | O14746 | 3/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.36 |
| ▸ | PPARD | Q03181 | 3/20 | 0.36 |
| ▸ | PPARA | Q07869 | 3/20 | 0.36 |
| ▸ | TOP1 | P11387 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | FABP4 | P15090 | 2/20 | 0.36 |
| ▸ | F7 | P08709 | 2/20 | 0.36 |
| ▸ | F3 | P13726 | 2/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1976479 | 1.00 | FFAR3 (0.39) | FFAR3PPARGTERTPTPN1PPARD | |
| SCHEMBL20529760 | 0.87 | F7 (0.52) | PPARGTERTPTPN1PPARDPPARA | |
| SCHEMBL20529770 | 0.85 | PPARG (0.55) | PPARGTERTPTPN1PPARDPPARA | |
| SCHEMBL22558363 | 0.84 | TERT (0.58) | PPARGTERTPTPN1PPARDPPARA | |
| SCHEMBL6137570 | 0.83 | PPARG (0.34) | PPARGTERTPTPN1PPARDPPARA | |
| SCHEMBL20529762 | 0.81 | FFAR3 (0.43) | FFAR3PPARGPPARDPPARAMAPT | |
| SCHEMBL3500945 | 0.75 | CA12 (0.43) | MAPTHSD17B10LMNACYP1A2ALOX15 | |
| SCHEMBL20529778 | 0.73 | FFAR3 (0.38) | FFAR3BLMHSD17B10LMNAALOX15 | |
| SCHEMBL20529777 | 0.73 | FFAR3 (0.38) | FFAR3BLMHSD17B10LMNAALOX15 | |
| SCHEMBL11213104 | 0.73 | TAS1R3 (0.33) | PPARGTERTPTPN1PPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304622-A1 | SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2025-10-02 | — | — | US | claimed |
| CN-119233984-A | Short apolipoprotein E mimetic peptides and methods of use thereof | 美国政府(由卫生和人类服务部的部长所代表) | 2024-12-31 | — | — | CN | claimed |
| US-20240309065-A1 | SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2024-09-19 | — | — | US | claimed |
| EP-4359432-A2 | SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2024-05-01 | — | — | EP | claimed |
| CN-117580857-A | APOC-II short mimetic peptides and methods of use | 美国政府(由卫生和人类服务部的部长所代表) | 2024-02-20 | — | — | CN | claimed |
| WO-2022271814-A2 | SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-12-29 | — | — | WO | claimed |
| EP-3962933-A1 | SELECTIVE TARGETING OF UBIQUITIN- AND UBIQUITIN-LIKE E1-ACTIVATING ENZYMES BY STRUCTURALLY-STABILIZED PEPTIDES | Dana-Farber Cancer Institute, Inc. (US) | 2022-03-09 | — | — | EP | claimed |
| CN-114026113-A | Selective targeting of ubiquitin and ubiquitin-like E1 activating enzymes by structurally stabilized peptides | 丹娜法伯癌症研究院 | 2022-02-08 | — | — | CN | claimed |
| US-20210324029-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | Bioniz Therapeutics, Inc. | 2021-10-21 | — | — | US | claimed |
| WO-2021127493-A1 | STRUCTURALLY-STABILIZED GLUCAGON-LIKE PEPTIDE 1 PEPTIDES AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2021-06-24 | — | — | WO | claimed |
| US-10774114-B2 | Respiratory syncytial virus (RSV) replication inhibitors | FONDATION THE ARK (CH) | 2020-09-15 | — | — | US | claimed |
| EP-3606940-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | Bioniz, LLC (US) | 2020-02-12 | — | — | EP | claimed |
| WO-2018187499-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | BIONIZ, LLC (US) | 2018-10-11 | — | — | WO | claimed |
| US-20260041753-A1 | RESPIRATORY SYNCYTIAL VIRUS SURFACE GLYCOPROTEIN PEPTIDES, CONJUGATES, AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2026-02-12 | — | — | US | disclosed |
| EP-4676512-A2 | RESPIRATORY SYNCYTIAL VIRUS SURFACE GLYCOPROTEIN PEPTIDES, CONJUGATES, AND USES THEREOF | Dana Farber Cancer Institute, Inc. (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-4676938-A2 | HENDRA VIRUS AND NIPAH VIRUS SURFACE GLYCOPROTEIN PEPTIDES, CONJUGATES, AND USES THEREOF | Dana-Farber Cancer Institute, Inc. (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20100184645-A1 | STITCHED POLYPEPTIDES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2010-07-22 | — | — | US | disclosed |
| WO-2010011313-A2 | LIGATION OF STAPLED POLYPEPTIDES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-01-28 | — | — | WO | disclosed |
| EP-2142562-A2 | STITCHED POLYPEPTIDES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-01-13 | — | — | EP | disclosed |
| WO-2008121767-A2 | STITCHED POLYPEPTIDES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2008-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184645-A1 | STITCHED POLYPEPTIDES | VIP, IAPP, NGLY1 | FFAR3 2988/4885PPARG 4770/4885TERT 1744/4885 |
| US-20210324029-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | IL2, IL2RA, GMFG | FFAR3 4567/4885PPARG 1025/4885TERT 3082/4885 |
| US-20260041753-A1 | RESPIRATORY SYNCYTIAL VIRUS SURFACE GLYCOPROTEIN PEPTIDES, CONJUGATES, AND USES THEREOF | CETP, HDLBP, NR1H3 | FFAR3 2312/4885PPARG 1206/4885TERT 3570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.